Chauvergne 1993.
Methods | RCT 1982‐1987 | |
Participants | 182 (13*) IIB‐N1, III, M0 | |
Interventions | CT + RT vs RT CT: CDDP 80 mg/m2 MTX 30 mg/m2 CLB 20 mg/m2 VCR 0.7 mg/m2. Every 21 days for 2 cycles and further 2 to responders. RT: External beam 50Gy. Intracavitary 18 y |
|
Outcomes | Survival Disease‐free survival Loco‐regional disease‐free survival Metastases‐free survival | |
Notes | Treatment comparison 1 | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Unclear risk | B ‐ Unclear |